on 30 May 2014
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 30 May 2014 to consider and approve the Standalone & Consolidated Audited Accounts for the Quarter & Year Ended 31 March 2014, after these accounts are reviewed by Audit Committee, to recommend dividend on Equity shares for the year ended 31 March 2014, if any, to discuss issuance of securities on Preferential basis by way of issue of Equity Shares/Preference Shares/Convertible Warrants/Cumulative Convertible Preference Shares/Cumulative Convertible Bonds/Debentures not exceeding Rupees 25 Crores (shall include premium thereon), to increase the Authorised Capital of the Company, and to alter Memorandum and Articles of Association of Company.Powered by Capital Market - Live News